MGTX earnings date and last-quarter result: next report 2026-08-13, last quarter miss, P/E -8.22. Updated 2026-07-23.
MeiraGTx Holdings (MGTX) Research Hub
MeiraGTx Holdings (MGTX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 9.18 USD (-0.33%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -8.22, market cap 1.13B. This hub links to the full technical, earnings and options research available for MGTX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 9.18 USD (-0.33%) |
| 52-week range | 9.05 USD – 15.35 USD |
| Trend regime | Range |
| 14-day RSI | 34.5 (Bearish) |
| Trailing P/E | -8.22 |
| Market cap | 1.13B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for MGTX
Covered Call on MGTX: how it works, illustrative setup around the real 9.18 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MGTX: how it works, illustrative setup around the real 9.18 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MGTX: how it works, illustrative setup around the real 9.18 USD price, max profit/loss, breakeven and when to use it. Educational.
MGTX technical analysis: range, last 9.18 USD, RSI 34.5, 52w range 9.05 USD–15.35 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is MGTX in?
MeiraGTx Holdings (MGTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MGTX in an uptrend or downtrend?
As of 2026-10-26, MGTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MGTX's trailing P/E ratio?
MGTX's trailing P/E is -8.22, with a market cap of 1.13B. See the earnings research page for full valuation detail.
When does MGTX next report earnings?
MGTX is next scheduled to report earnings on 2026-08-13.